WHO ICTRP trial
Study on the guiding role of laparoscopic indocyanine green fluorescence imaging…
ChiCTR2100046388 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2100046388 |
|---|---|
| Public title | Study on the guiding role of laparoscopic indocyanine green fluorescence imaging in lymph node resection of endometrial cancer |
| Scientific title | Study on the guiding role of laparoscopic indocyanine green fluorescence imaging in lymph node resection of endometrial cancer |
| Primary sponsor | Beijing Obstetrics and Gynecology Hospital, Capital Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Diagnostic test |
| Phase | 0 |
| Countries | China |
| Conditions | Endometrial cancer |
| Interventions | Gold Standard:Pathology;Index test:Laparoscopic indocyanine green fluorescence imaging. |
| Registration date | May 15, 2021 |
| Target size | Target condition:368;Difficult condition:0 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: